Synopsis
0
USDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
About the Company : Inabata France, established in 1990 and part of the Inabata Group, acquired Pharmasynthèse in 2006. Today, Inabata-Pharmasynthèse offers sourcing, manufacturing, and development ...
Jai Radhe Sales is your partner for all your sourcing needs.
About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...
China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress
About the Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in API and advanced intermediate R&D and manufacturing, delivering comprehensive CDMO/CRO/OEM services and Finished ...
Together we can improve the quality of life
About the Company : Shamrock Pharmachemi Pvt Ltd. is a globally recognized API leader with 26+ years in human and veterinary pharmaceuticals. Operating in 40+ countries, it owns two Gujarat facilities...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
APIs
Reply
25 Sep 2025
Reply
22 Apr 2025
Reply
15 Mar 2025
Reply
30 Aug 2022
Reply
23 Dec 2021
Reply
09 Aug 2021
Reply
15 Jul 2020
Reply
22 May 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
45
PharmaCompass offers a list of Cinchocaine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cinchocaine Hydrochloride manufacturer or Cinchocaine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cinchocaine Hydrochloride manufacturer or Cinchocaine Hydrochloride supplier.
A Cinchocaine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cinchocaine Hydrochloride, including repackagers and relabelers. The FDA regulates Cinchocaine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cinchocaine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cinchocaine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Cinchocaine Hydrochloride supplier is an individual or a company that provides Cinchocaine Hydrochloride active pharmaceutical ingredient (API) or Cinchocaine Hydrochloride finished formulations upon request. The Cinchocaine Hydrochloride suppliers may include Cinchocaine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Cinchocaine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cinchocaine Hydrochloride Drug Master File in Japan (Cinchocaine Hydrochloride JDMF) empowers Cinchocaine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cinchocaine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Cinchocaine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cinchocaine Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cinchocaine Hydrochloride Drug Master File in Korea (Cinchocaine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cinchocaine Hydrochloride. The MFDS reviews the Cinchocaine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Cinchocaine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cinchocaine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cinchocaine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cinchocaine Hydrochloride suppliers with KDMF on PharmaCompass.
A Cinchocaine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Cinchocaine Hydrochloride Certificate of Suitability (COS). The purpose of a Cinchocaine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cinchocaine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cinchocaine Hydrochloride to their clients by showing that a Cinchocaine Hydrochloride CEP has been issued for it. The manufacturer submits a Cinchocaine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cinchocaine Hydrochloride CEP holder for the record. Additionally, the data presented in the Cinchocaine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cinchocaine Hydrochloride DMF.
A Cinchocaine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cinchocaine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cinchocaine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Cinchocaine Hydrochloride written confirmation (Cinchocaine Hydrochloride WC) is an official document issued by a regulatory agency to a Cinchocaine Hydrochloride manufacturer, verifying that the manufacturing facility of a Cinchocaine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cinchocaine Hydrochloride APIs or Cinchocaine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Cinchocaine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Cinchocaine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cinchocaine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cinchocaine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cinchocaine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cinchocaine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cinchocaine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cinchocaine Hydrochloride suppliers with NDC on PharmaCompass.
Cinchocaine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cinchocaine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cinchocaine Hydrochloride GMP manufacturer or Cinchocaine Hydrochloride GMP API supplier for your needs.
A Cinchocaine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Cinchocaine Hydrochloride's compliance with Cinchocaine Hydrochloride specifications and serves as a tool for batch-level quality control.
Cinchocaine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Cinchocaine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cinchocaine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Cinchocaine Hydrochloride EP), Cinchocaine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cinchocaine Hydrochloride USP).
Comment (3)
